Biosimilars in oncology: Effects on economy and therapeutic innovations.
Sign Up to like & getrecommendations! Published in 2020 at "European journal of cancer"
DOI: 10.1016/j.ejca.2020.07.037
Abstract: AIM The introduction of new and innovative treatment options for cancer patients is accompanied by a tremendous increase in healthcare costs. Consequently, new financing approaches are strongly needed to reduce the burden on the healthcare… read more here.
Keywords: healthcare; biosimilars oncology; mio eur; healthcare system ... See more keywords
Cost savings of biosimilars in oncology: A single institution experience.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.29_suppl.10
Abstract: 10Background: Biosimilar medications have increasingly gained regulatory approvals in recent years. Numerous conditions in the fields of hematology, oncology, rheumatology, and endocrinology have a... read more here.
Keywords: oncology single; savings biosimilars; oncology; single institution ... See more keywords
Biosimilars in Oncology: Latest Trends and Regulatory Status
Sign Up to like & getrecommendations! Published in 2022 at "Pharmaceutics"
DOI: 10.3390/pharmaceutics14122721
Abstract: Biologic-based medicines are used to treat a variety of diseases and account for around one-quarter of the worldwide pharmaceutical market. The use of biologic medications among cancer patients has resulted in substantial advancements in cancer… read more here.
Keywords: biosimilars oncology; oncology; oncology latest; latest trends ... See more keywords